Israel Wiznitzer

Assistant Professor of Clinical

  • 1021 Citations
1985 …2017
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Israel Wiznitzer is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 3 Similar Profiles
Breast Neoplasms Medicine & Life Sciences
Fluoresceins Medicine & Life Sciences
Thrombopoiesis Medicine & Life Sciences
Histocytochemistry Medicine & Life Sciences
Diethylstilbestrol Medicine & Life Sciences
Competitive Binding Medicine & Life Sciences
Idiopathic Thrombocytopenic Purpura Medicine & Life Sciences
Bovine Serum Albumin Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1985 2017

  • 1021 Citations
  • 5 Article
  • 1 Chapter
126 Citations (Scopus)
Breast Neoplasms
Disease-Free Survival
386 Citations (Scopus)

AMG 531, a thrombopoiesis-stimulating protein, for chronic ITP

Bussel, J. B., Kuter, D. J., George, J. N., McMillan, R., Aledort, L. M., Conklin, G. T., Lichtin, A. E., Lyons, R. M., Nieva, J., Wasser, J. S., Wiznitzer, I., Kelly, R., Chen, C. F. & Nichol, J. L., Oct 19 2006, In : New England Journal of Medicine. 355, 16, p. 1672-1681 10 p.

Research output: Contribution to journalArticle

Idiopathic Thrombocytopenic Purpura
Platelet Count
Blood Platelets
13 Citations (Scopus)

A phase II study to determine the efficacy and tolerability of intravenous ZD9331 in heavily pretreated patients with ovarian cancer

Rader, J. S., Clarke-Pearson, D., Moore, M., Carson, L., Holloway, R., Kao, M. S., Wiznitzer, I. & Douglass, E. C., Nov 1 2003, In : Gynecologic Oncology. 91, 2, p. 318-325 8 p.

Research output: Contribution to journalArticle

Ovarian Neoplasms
Disease Progression
ZD 9331
Thymidylate Synthase

Bone pain associated with once-per-cycle pegfilgrastim is similar to daily filgrastim in patients with breast cancer

Kubista, E., Glaspy, J., Holmes, F. A., Green, M. D., Hackett, J., Neumann, T., Marques, F., Meza, L., Miles, D., Moore, M., O'Shaughnessy, J., Piccart, M. J., Richardson, G. E., Samonigg, H., Santoro, A., Savin, M., Schaafsma, M. R., Siena, S., Shogan, J., Vukelja, S. & 1 others, Wiznitzer, I., Jan 1 2003, In : Clinical Breast Cancer. 3, 6, p. 391-398 8 p.

Research output: Contribution to journalArticle

Breast Neoplasms
Bone and Bones
Drug Therapy
438 Citations (Scopus)

Blinded, randomized, multicenter study to evaluate single administration pegfilgrastim once per cycle versus daily filgrastim as an adjunct to chemotherapy in patients with high-risk stage II or stage III/IV breast cancer

Holmes, F. A., O'Shaughnessy, J. A., Vukelja, S., Jones, S. E., Shogan, J., Savin, M., Glaspy, J., Moore, M., Meza, L., Wiznitzer, I., Neumann, T. A., Hill, L. R. & Liang, B. C., Feb 1 2002, In : Journal of Clinical Oncology. 20, 3, p. 727-731 5 p.

Research output: Contribution to journalArticle

Multicenter Studies
Breast Neoplasms
Drug Therapy